Endpoints News

Novo Holdings CEO discusses investments, geopolitics and China

Published

3 weeks ago

on

The assets managed by Novo Holdings, the controlling shareholder of Novo Nordisk, fell by some 35% last year. But that doesn’t mean it will rein in its biotech investments in the year …

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version